Cognitive and Speech Disorders in Children With Congenital Heart Defects
1 other identifier
observational
217
1 country
1
Brief Summary
The study is aimed to found out expressive speech disorders as a sign of neurocognitive development delay in children with congenital heart defects before and after surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 12, 2024
CompletedFirst Posted
Study publicly available on registry
August 21, 2024
CompletedAugust 21, 2024
August 1, 2024
5.4 years
August 12, 2024
August 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neurocognitive status
Monitoring before the cardiovascular operation and in postoperative period (in 1 and 2 years). Assessment of speech disorders, short-term and long-term memory impairments.
2 years
Study Arms (2)
Group 1
Children with family anamnesis confounding factorss, such as family composition, living conditions, conflict families (members of family suffering from any type of addiction, prisoned members of family, conflicts in front of a child's eyes).
Group 2
without family anamnesis confounding factors
Interventions
Cardiovascular surgery about congenital heart defects with cardiopulmonary bypass
Eligibility Criteria
5-7 years old children with congenital heart defects bofore abd after cardiovascular operation with cardiopulmonary bypass
You may qualify if:
- children with congenital heart disease that required total correction using cardiopulmonary bypass
You may not qualify if:
- patients with heart disease requiring palliative or endovascular correction, as well as children with chromosomal and genetic diseases (determined by karyotyping)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aleksandra Aeksandrovna Rumiantseva
Kemerovo, Kemerovo Oblast, 650066, Russia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the Department of Anesthesiology
Study Record Dates
First Submitted
August 12, 2024
First Posted
August 21, 2024
Study Start
March 1, 2019
Primary Completion
August 1, 2024
Study Completion
August 1, 2024
Last Updated
August 21, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share